Biotechnological Advances in Genetic Disease Screening
American Journal of Biotechnology · 31.12.2025 · 6 (6) · 1-5
DOI: 10.71465/ajbt3490 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Biotechnology, online erschienen am 31.12.2025. Verfasst von Austra Lian und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Genetic diseases are a significant global health concern, with millions of individuals affected by inherited disorders. Advances in biotechnology have revolutionized the field of genetic disease screening, enabling early detection, accurate diagnosis, and personalized treatment options. Technologies such as next-generation sequencing (NGS), CRISPR-based tools, and gene editing have opened new avenues for screening genetic disorders, allowing for precise identification of mutations and variants. This article discusses recent biotechnological advances in genetic disease screening, focusing on their impact on healthcare, challenges in implementation, and future directions.
Zitieren
APA
Lian, A., Taylor, S. M., & Richards, E. (2025). Biotechnological Advances in Genetic Disease Screening. American Journal of Biotechnology, 6(6), 1-5. https://doi.org/10.71465/ajbt3490
Vancouver
Lian A, Taylor SM, Richards E. Biotechnological Advances in Genetic Disease Screening. American Journal of Biotechnology. 2025;6(6):1-5. doi:10.71465/ajbt3490
BibTeX
@article{Lian2025,
author = {Lian, Austra and Taylor, Screening Michael and Richards, Emma},
title = {Biotechnological Advances in Genetic Disease Screening},
journal = {American Journal of Biotechnology},
year = {2025},
volume = {6},
number = {6},
pages = {1--5},
doi = {10.71465/ajbt3490}
}
EUVIMED